Eleonore Pauwels is a writer and international science policy expert, who specializes in the governance of emerging and converging technologies. At the Wilson Center, she is the director of the Anticipatory Intelligence (AI) Lab within the Science and Technology Innovation Program. In this context, Pauwels analyzes, compares, and decodes how emerging transformative technologies, such as artificial intelligence, genomics and genome-editing, raise new opportunities and challenges for health, security, economics and governance in different geo-political contexts. She analyzes the promises and perils that will likely arise with the development of AI civil and military technologies, the Internet of Living Things and future networks of intelligent and connected bio-labs.
Pauwels regularly testifies before U.S. and European authorities including the U.S. Department of State, NAS, NIH, NCI, FDA, the National Intelligence Council, the European Commission and the UN. But she is also well-versed in communicating complex and novel scientific developments for lay audiences (her TEDxCERN on CRISPR) and her writing has been featured in media outlets such as Nature, The New York Times, The Guardian, Scientific American, Le Monde, Slate and The Miami Herald.
Outside of the Wilson Center, Pauwels is an aspiring social entrepreneur interested in democratizing science and technology, in particular AI, genomics and biology, for underserved populations in the USA and globally. Bilingual in French and English, her blog can be found here.
Science, Technology and Innovation Policy; Citizen Science; Innovation Ecosystems;Converging Technologies; Artificial Intelligence; Genomics, Genome-editing, Precision Medicine, Synthetic Biology, Nanotechnology; Society and Culture; Governance; Europe; European Union; United States; Asia, Mexico
Her work also fosters the democratization of disruptive health technologies, including AI and genomics, and the inclusion of patients and citizens through participatory health design. With funding from the Robert Wood Johnson Foundation, Pauwels leads the Citizen Health Innovators Project. With this venture, she focuses on developing regulatory and governance mechanisms for the fast-growing ecosystem of health innovators, built around maker-spaces and community bio labs, to support responsible innovation in distributed networks. This project is part of her larger effort to design actionable ethics and governance strategies to enable responsible and fair citizen particpation in new health and genomics technologies.
Pauwels has been awarded several grants by U.S and European institutions, including the U.S. National Science Foundation and the European institutions, including the U.S. National Science Foundation and the European Commission. She is co-PI of a 4 million Euro grant, Synenergene, which promotes responsible research and innovation in genomics and synthetic biology.